Showing results (1-10 of 93) with videos related to
Sort By:
Pageof 10
Cells|January 20, 2021
Developing New Anti-Tuberculosis Vaccines: Focus on AdjuvantsAna Rita Franco, Francesco PeriMethods in Molecular Biology (Clifton, N.J.)|August 21, 2023
Use of Fluorescent Chemical Probes in the Study of Toll-like Receptors (TLRs) TraffickingAna Rita Franco, Valentina Artusa, Francesco PeriInternational Journal of Molecular Sciences|November 11, 2022
A Global Picture of Molecular Changes Associated to LPS Treatment in THP-1 Derived Human Macrophages by Fourier Transform Infrared MicrospectroscopyDiletta Ami, Ana Rita Franco, Valentina Artusa, et al.ACS Omega|October 9, 2023
Overcoming Challenges in Chemical Glycosylation to Achieve Innovative Vaccine Adjuvants Possessing Enhanced TLR4 ActivityAlessio Romerio, Ana Rita Franco, Melanie Shadrick, et al.RSC Medicinal Chemistry|March 24, 2025
Towards more efficient synthetic immunomodulators: biological characterization and mechanism of action of monosaccharide-derived TLR4 agonistsAna Rita Franco, Zaineh Aladailleh, Alessio Romerio, et al.Talanta|April 27, 2024
Vibrational spectroscopy coupled with machine learning sheds light on the cellular effects induced by rationally designed TLR4 agonistsDiletta Ami, Ana Rita Franco, Valentina Artusa, et al.Mini Reviews in Medicinal Chemistry|October 8, 2003
Extending chemoselective ligation to sugar chemistry: convergent assembly of bioactive neoglycoconjugatesFrancesco PeriChemical Society Reviews|December 20, 2012
Clustered carbohydrates in synthetic vaccinesFrancesco PeriACS Infectious Diseases|March 25, 2025
Monosaccharide-Based Synthetic TLR4 Agonist Enhances Vaccine Efficacy against Pseudomonas aeruginosa ChallengeMaite Sainz-Mejías, Chaoying Ma, Yueran Hou, et al.Journal of Medicinal Chemistry|March 21, 2024
Novel TLR4-Activating Vaccine Adjuvant Enhances the Production of Enterococcus faecium-binding AntibodiesAna Rita Franco, Océane Sadones, Alessio Romerio, et al.Pageof 10